22 related articles for article (PubMed ID: 221714)
1. T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo.
Henningsson CM; Selvaraj S; MacLean GD; Suresh MR; Noujaim AA; Longenecker BM
Cancer Immunol Immunother; 1987; 25(3):231-41. PubMed ID: 2445486
[TBL] [Abstract][Full Text] [Related]
2. Unique Glycoform-Dependent Monoclonal Antibodies for Mouse Mucin 21.
Nishida J; Shichino S; Tsukui T; Hoshino M; Okada T; Okada K; Yi Y; Toraya-Brown S; Mochizuki M; Koizumi R; Ishii-Schrade K; Denda-Nagai K; Irimura T
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743163
[TBL] [Abstract][Full Text] [Related]
3. Mucin 21/epiglycanin modulates cell adhesion.
Yi Y; Kamata-Sakurai M; Denda-Nagai K; Itoh T; Okada K; Ishii-Schrade K; Iguchi A; Sugiura D; Irimura T
J Biol Chem; 2010 Jul; 285(28):21233-40. PubMed ID: 20388707
[TBL] [Abstract][Full Text] [Related]
4. Specificity studies of an antibody developed against a mucin-type glycoprotein.
Haavik S; Nilsen M; Thingstad T; Barsett H; Renouf DV; Hounsell EF; Codington JF
Glycoconj J; 1999 Mar; 16(3):229-36. PubMed ID: 10596898
[TBL] [Abstract][Full Text] [Related]
5. Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma.
Codington JF; Cooper AG; Miller DK; Slayter HS; Brown MC; Silber C; Jeanloz RW
J Natl Cancer Inst; 1979 Jul; 63(1):153-61. PubMed ID: 286825
[TBL] [Abstract][Full Text] [Related]
6. Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell.
Miller SC; Codington JF; Klein G
J Natl Cancer Inst; 1982 Jun; 68(6):981-8. PubMed ID: 6953278
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A.
Codington JF; Dalianis T; Miller SC; Das HR; Klein G; Lampert LA; Silber C; Darby DM; Jeanloz RW
Cancer Res; 1983 Sep; 43(9):4364-72. PubMed ID: 6871869
[TBL] [Abstract][Full Text] [Related]
8. Comparative lectin-binding and agglutination properties of the strain-specific, TA-3-St, and the non-strain-specific, TA3-Ha, murine mammary carcinoma ascites sublines. Further studies of receptors in epiglycanin.
Matsumoto I; Codington JF; Jahnke MR; Jeanloz RW; Osawa T
Carbohydr Res; 1980 Apr; 80(1):179-89. PubMed ID: 7363275
[TBL] [Abstract][Full Text] [Related]
9. Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection.
Codington JF; Das HR; Dalianis T; Klein G; Miller SC; Silber C; Lampert LA; Darby DM; Jeanloz RW
Cancer Res; 1983 Sep; 43(9):4373-81. PubMed ID: 6871870
[TBL] [Abstract][Full Text] [Related]
10. Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth.
Cooper AG; Codington JF; Miller DK; Brown MC
J Natl Cancer Inst; 1979 Jul; 63(1):163-9. PubMed ID: 221714
[TBL] [Abstract][Full Text] [Related]
11. The role of integrins and integrin activation in liver metastasis.
Kemperman H; Driessens M; La Rivière G; Meijne AM; Roos E
Invasion Metastasis; 1994-1995; 14(1-6):98-108. PubMed ID: 7657536
[TBL] [Abstract][Full Text] [Related]
12. Epiglycanin--a carcinoma-specific mucin-type glycoprotein of the mouse TA3 tumour.
Codington JF; Haavik S
Glycobiology; 1992 Jun; 2(3):173-80. PubMed ID: 1498415
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
